StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Glucotrack's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.22M. For fiscal 2025 it was -$15.24M. The highest annual figure on record is -$1.16M in fiscal 2009.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.24M–
FY2024Dec 31, 2024-$12.49M–
FY2023Dec 31, 2023-$6.56M–
FY2022Dec 31, 2022-$3.73M–
FY2021Dec 31, 2021-$3.77M–
FY2020Dec 31, 2020-$3.50M–
FY2019Dec 31, 2019-$3.90M–
FY2018Dec 31, 2018-$4.89M–
FY2017Dec 31, 2017-$5.90M–
FY2016Dec 31, 2016-$5.31M–
FY2015Dec 31, 2015-$4.57M–
FY2014Dec 31, 2014-$3.36M–
FY2013Dec 31, 2013-$3.22M–
FY2012Dec 31, 2012-$2.30M–
FY2011Dec 31, 2011-$1.92M–
FY2010Dec 31, 2010-$1.37M–
FY2009Dec 31, 2009-$1.16M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.62M–
Q1 FY2026Mar 31, 2026-$4.05M–
Q4 FY2025Dec 31, 2025-$3.94M–
Q3 FY2025Sep 30, 2025-$4.62M–
Q2 FY2025Jun 30, 2025-$3.74M–
Q1 FY2025Mar 31, 2025-$2.94M–
Q4 FY2024Dec 31, 2024-$3.50M–
Q3 FY2024Sep 30, 2024-$4.14M–
Q2 FY2024Jun 30, 2024-$1.91M–
Q1 FY2024Mar 31, 2024-$2.94M–
Q4 FY2023Dec 31, 2023-$2.41M–
Q3 FY2023Sep 30, 2023-$1.88M–
Q2 FY2023Jun 30, 2023-$954.00K–
Q1 FY2023Mar 31, 2023-$1.31M–
Q4 FY2022Dec 31, 2022-$940.00K–
Q3 FY2022Sep 30, 2022-$608.00K–
Q2 FY2022Jun 30, 2022-$916.00K–
Q1 FY2022Mar 31, 2022-$1.27M–
Q4 FY2021Dec 31, 2021-$973.00K–
Q3 FY2021Sep 30, 2021-$894.00K–
Q2 FY2021Jun 30, 2021-$969.00K–
Q1 FY2021Mar 31, 2021-$933.00K–
Q4 FY2020Dec 31, 2020-$844.00K–
Q3 FY2020Sep 30, 2020-$765.00K–
Q2 FY2020Jun 30, 2020-$903.00K–
Q1 FY2020Mar 31, 2020-$989.00K–
Q4 FY2019Dec 31, 2019-$796.49K–
Q3 FY2019Sep 30, 2019-$1.06M–
Q2 FY2019Jun 30, 2019-$1.22M–
Q1 FY2019Mar 31, 2019-$821.02K–
Q4 FY2018Dec 31, 2018-$1.09M–
Q3 FY2018Sep 30, 2018-$1.36M–
Q2 FY2018Jun 30, 2018-$1.02M–
Q1 FY2018Mar 31, 2018-$1.43M–
Q4 FY2017Dec 31, 2017-$788.01K–
Q3 FY2017Sep 30, 2017-$1.50M–
Q2 FY2017Jun 30, 2017-$2.46M–
Q1 FY2017Mar 31, 2017-$1.15M–
Q4 FY2016Dec 31, 2016-$965.54K–
Q3 FY2016Sep 30, 2016-$1.46M–

More Glucotrack figures

See a number that looks wrong?